|
 The verdict, in California Superior Court in Oakland, marks the
latest defeat for the healthcare conglomerate facing more than
13,000 talc-related lawsuits nationwide.
J&J said it would appeal, citing "serious procedural and evidentiary
errors" in the course of the trial, saying lawyers for the woman had
fundamentally failed to show its baby powder contains asbestos. The
company did not provide further details of the alleged errors during
the trial.
"We respect the legal process and reiterate that jury verdicts are
not medical, scientific or regulatory conclusions about a product,"
J&J said in a statement on Wednesday.
The New Brunswick, New Jersey-based company denies that its talc
causes cancer, saying numerous studies and tests by regulators
worldwide have shown that its talc is safe and asbestos-free.
The lawsuit was brought by Terry Leavitt, who said she used
Johnson's Baby Powder and Shower to Shower - another powder
containing talc sold by J&J in the past - in the 1960s and 1970s and
was diagnosed with mesothelioma in 2017. It was the first of more
than a dozen J&J talc cases scheduled for trial in 2019. The
nine-week trial began on Jan. 7 and included testimony from nearly a
dozen experts on both sides.
The jury deliberated for two days before delivering its verdict,
which was broadcast online by Courtroom View Network.
Jurors found that J&J's talc-based products used by Leavitt were
defective and that the company had failed to warn consumers of the
health risks, awarding $29.4 million in damages to Leavitt and her
husband. The jury declined to award punitive damages.
"Yet another jury has rejected J&J’s misleading claims that its talc
was free of asbestos," said Moshe Maimon, a lawyer for Leavitt, in a
statement on Wednesday. "The internal J&J documents that the jury
saw, once more laid bare the shocking truth of decades of cover- up,
deception and concealment by J&J."
[to top of second column] |
Leavitt's was the first talc case to go to trial since Reuters on
Dec. 14 published a report detailing that J&J knew that the talc in
its raw and finished powders sometimes tested positive for small
amounts of asbestos from the 1970s into the early 2000s - test
results it did not disclose to regulators or consumers.
Leavitt's trial originally included J&J's talc supplier, Imerys Talc
America, a unit of Imerys SE, as a co-defendant. California Superior
Court Judge Brad Seligman, who oversaw the trial, told jurors in
February that the company was no longer part of the case after it
filed for Chapter 11 bankruptcy protection under the weight of the
talc litigation, which stayed lawsuits against it.
While earlier talc lawsuits alleged talc itself causes ovarian
cancer, plaintiffs' lawyers have more recently focused on arguing
asbestos contamination in talc caused ovarian cancer and
mesothelioma, a form of cancer linked to asbestos exposure.
In 11 cases so far alleging asbestos contamination in talc, three
have resulted in wins for plaintiffs, awarding damages as high as
$4.69 billion in a July 2018 multi-plaintiff ovarian cancer verdict.
J&J won three other cases and another five ended in hung juries.
J&J has appealed all of the plaintiff verdicts, and the company said
it is confident the verdicts would be overturned on appeal.
(Read the documents that sparked the investigation -
https://www.reuters.com
/investigates/special-report/johnsonandjohnson-cancer/)
(Reporting by Tina Bellon and additional reporting by Ismail Shakil
in Bengaluru; Editing by Bill Rigby)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
 |
